Jonah Feldman | Authors

Articles

Premarket Approval Submitted for Noninvasive CRC Screening Test

January 26, 2023

Results from the CRC-PREVENT trial of a noninvasive diagnostic screening test have led to the submission of a premarket approval application to the FDA for patients with colorectal cancer and advanced adenomas.